Search - tctmd.com

Displaying 1 - 20 of 281

Sort: Relevancy | Date

News Daily News

Top Endovascular News of 2024

L.A. McKeown

December 28, 2024

News Daily News

Top Coronary Artery Disease News in 2024

Michael O'Riordan

December 26, 2024

News Daily News

More Surgical Team Familiarity Could Trim Cardiopulmonary Bypass Time

Yael L. Maxwell

December 18, 2024

News Daily News

Editor’s Pick: TCTMD’s Best Long Reads of 2024

Shelley Wood

December 17, 2024

News Daily News

FDA Issues Safety Communication for Some Accolade Pacemakers

L.A. McKeown

December 16, 2024

News Daily News

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

L.A. McKeown

December 12, 2024

News Daily News

Sudden Cardiac Death in Athletes Is Rare, but Affects Black Population More

Michael O'Riordan

December 06, 2024

News Daily News

Questions Raised Anew About Aspirin for Secondary Prevention of ASCVD

Todd Neale

December 06, 2024

News Daily News

EXCEL Data Highlight Bleeding Patterns After CABG, PCI for LM Disease

Yael L. Maxwell

December 05, 2024

Sustained Benefit With Pascal TEER Device at 2 Years: CLASP IID and MiCLASP

Michael O'Riordan

December 05, 2024

News Daily News

IVC Filter Lawsuits Expose Holes in FDA Oversight and Public Communication

L.A. McKeown

December 03, 2024

News Conference News PCR London Valves 2024

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

Michael O'Riordan

November 25, 2024

News Conference News AHA 2024

Infections No More Likely With Reconditioned Versus New Pacemakers

Yael L. Maxwell

November 22, 2024

News Conference News AHA 2024

Novel CRISPR-Cas9 Therapy Slows ATTR-CM Progression

Yael L. Maxwell

November 20, 2024

News Conference News AHA 2024

Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360

Michael O'Riordan

November 18, 2024

News Conference News AHA 2024

OPTION: LAAO Matches Up to DOACs After Ablation, but Questions Remain

Todd Neale

November 18, 2024

News Conference News AHA 2024

Nasal Bumetanide Safe, Effective in Healthy Adults

Yael L. Maxwell

November 18, 2024

Presentation AHA 2024

Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement

Presenter: Chisato Izumi

November 17, 2024

News Conference News AHA 2024

Rivaroxaban Doesn’t Cut Cognitive Decline, Stroke, or TIA in Younger AF Patients

Shelley Wood

November 16, 2024

News Conference News AHA 2024

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

Shelley Wood

November 14, 2024

Advertisement

Top Endovascular News of 2024

Top Coronary Artery Disease News in 2024

More Surgical Team Familiarity Could Trim Cardiopulmonary Bypass Time

Editor’s Pick: TCTMD’s Best Long Reads of 2024

FDA Issues Safety Communication for Some Accolade Pacemakers

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

Sudden Cardiac Death in Athletes Is Rare, but Affects Black Population More

Questions Raised Anew About Aspirin for Secondary Prevention of ASCVD

EXCEL Data Highlight Bleeding Patterns After CABG, PCI for LM Disease

Sustained Benefit With Pascal TEER Device at 2 Years: CLASP IID and MiCLASP

IVC Filter Lawsuits Expose Holes in FDA Oversight and Public Communication

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

Infections No More Likely With Reconditioned Versus New Pacemakers

Novel CRISPR-Cas9 Therapy Slows ATTR-CM Progression

Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360

OPTION: LAAO Matches Up to DOACs After Ablation, but Questions Remain

Nasal Bumetanide Safe, Effective in Healthy Adults

Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement

Rivaroxaban Doesn’t Cut Cognitive Decline, Stroke, or TIA in Younger AF Patients

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content